Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Disintegration time determination is a critical quality control test in the pharmaceutical and dietary supplement industries, ensuring that tablets and capsules break down within a specified timeframe to release active ingredients. This article provides a comprehensive technical overview of disintegration testing methodologies, applicable standards, and equipment requirements for regulatory compliance.

Technical Overview

Disintegration testing is a fundamental pharmacopoeial test used to evaluate the physical properties of solid oral dosage forms, such as tablets, capsules, and granules. The test measures the time required for a dosage unit to disintegrate completely into particles or aggregate under standardized conditions. While it does not directly measure drug dissolution or absorption, disintegration is a crucial prerequisite for dissolution in most solid dosage forms. Regulatory pharmacopoeias, including the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Chinese Pharmacopoeia (ChP), provide strict guidelines for this procedure to ensure product consistency and bioavailability.

Testing Samples

The disintegration test is applicable to a wide range of solid dosage forms designed for oral or rectal administration. The specific testing parameters and acceptance criteria vary depending on the sample type.

Uncoated Tablets

Standard uncoated tablets are typically the simplest dosage forms to test. They generally have the shortest disintegration time limits, as there are no barrier layers to slow down the penetration of the test medium.

Coated Tablets

This category includes film-coated and sugar-coated tablets. The coating material can affect the disintegration time. The test method often allows for a slightly longer duration compared to uncoated tablets to account for the time needed for the medium to penetrate or dissolve the coating layer.

Capsules

Both hard and soft gelatin capsules are subject to disintegration testing. The test verifies that the gelatin shell ruptures or dissolves to release the contents. A disc may be used in the tube to prevent the capsule from floating.

Suppositories

For rectal suppositories, the testing conditions differ significantly. The apparatus usually operates in a horizontal position, and the medium is maintained at a specific temperature to simulate body conditions.

Testing Items

The primary objective of the test is to determine the disintegration time, which is the elapsed time from the start of the test until the sample completely disintegrates. The specific items evaluated include:

  • Complete disintegration time: The point at which no residue remains on the screen of the test apparatus, except for fragments of insoluble coating or capsule shell.
  • Medium penetration: How effectively the test medium (usually water or simulated gastric/intestinal fluid) interacts with the dosage form.
  • Physical integrity: Observing whether the sample swells, bursts, or dissolves progressively during the test cycle.

Testing Methods

The determination of disintegration time is performed using a specialized apparatus defined by pharmacopoeial standards. The general procedure involves placing the sample in a basket-rack assembly and immersing it in a fluid medium at a controlled temperature.

Apparatus Setup

The standard apparatus consists of a basket-rack assembly, a 1000 mL beaker, a thermostatic arrangement for heating the fluid, and a mechanical device for raising and lowering the basket. The basket-rack assembly contains six open-ended glass tubes with a wire mesh bottom (usually 1.8mm to 2.0mm mesh size). The apparatus operates with a reciprocating motion, moving the basket up and down at a constant frequency, typically 30 cycles per minute.

Test Medium and Temperature

Unless otherwise specified in the monograph, the test medium is usually water. In some cases, simulated gastric fluid or simulated intestinal fluid is used to mimic physiological conditions. The temperature of the medium must be maintained at 37 degrees Celsius plus or minus 1 degree Celsius throughout the test to simulate body temperature.

Procedure

A sample is placed in each of the six tubes of the basket-rack. If a disc is required, it is placed on top of the sample. The assembly is then immersed in the beaker containing the medium. The timer starts immediately. At the end of the specified time, the basket is lifted, and the state of the samples is inspected. The sample passes if all units have disintegrated. If one or two units fail, the test is often repeated with an additional set of samples to determine compliance.

Applications

Disintegration testing is vital across the pharmaceutical development and manufacturing lifecycle.

  • Quality Control: It is a routine release test for every batch of tablets and capsules to ensure manufacturing consistency.
  • Formulation Development: Scientists use the test to evaluate the impact of excipients, binder concentrations, and compression forces on the physical properties of a new tablet.
  • Stability Studies: Disintegration time is monitored over time to ensure that products do not harden or become resistant to breakdown during their shelf life.

FAQ

What is the difference between disintegration and dissolution?

Disintegration is the physical breakdown of a solid dosage form into granules or fine particles. Dissolution is the chemical process where the active pharmaceutical ingredient dissolves in the solvent to form a solution. Disintegration is usually a prerequisite for dissolution but does not guarantee it.

Why is a disc used in the test?

A disc is a plastic or metal weight placed on top of the sample in the tube. It is used to prevent tablets or capsules from floating to the surface of the medium and to ensure they remain submerged throughout the test cycle.

What standards govern this test?

The test is governed by major pharmacopoeias such as the USP (United States Pharmacopeia), EP (European Pharmacopoeia), BP (British Pharmacopoeia), and GB standards (Chinese Pharmacopoeia). Each organization specifies detailed requirements for apparatus design, media composition, and acceptance criteria.